Application of a liquid chromatographic/tandem mass spectrometric method to a urinary excretion study of rabeprazole and two of its metabolites in healthy human urine. 2015

Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
Department of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.

To study urinary excretion properties of rabeprazole and two of its metabolites, i.e. rabeprazole thioether and desmethyl rabeprazole thioether in human urine, a sensitive, selective, accurate and precise method for the quantification of rabeprazole and two of its metabolites using a liquid chromatographic/tandem mass spectrometric method has been developed and validated. Starting with a 200 μL urine aliquot, a general sample preparation was performed using protein precipitation with methanol. Analytes were separated on a Dikma Inspire™ C18 column (150 mm × 2.1mm, 5 μm) using a mixture of methanol and aqueous 10mM ammonium acetate buffer containing 0.05% formic acid (55:45, v/v) as mobile phase. Linearity was obtained over the concentration range of 0.1446-96.38 ng/mL, 0.3198-319.8 ng/mL and 0.05160-82.53 ng/mL for rabeprazole, rabeprazole thioether, desmethyl rabeprazole thioether in human urine, respectively. The fully validated method was applied to a urine excretion study of rabeprazole sodium administered as a 30 min intravenous infusion for the first time. The calculated cumulative urinary recovery just reached 0.04745‰, 1.272‰ and 0.1631‰ of dose within 24h post-dose for rabeprazole, rabeprazole thioether, and desmethyl rabeprazole thioether, respectively, after intravenous infusion administration, indicating that rabeprazole and its two main metabolites undergo substantial non-renal elimination in healthy Chinese volunteers.

UI MeSH Term Description Entries
D008297 Male Males
D002853 Chromatography, Liquid Chromatographic techniques in which the mobile phase is a liquid. Liquid Chromatography
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013440 Sulfides Chemical groups containing the covalent sulfur bonds -S-. The sulfur atom can be bound to inorganic or organic moieties. Sulfide,Thioether,Thioethers,Sulfur Ethers,Ethers, Sulfur
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face
D016014 Linear Models Statistical models in which the value of a parameter for a given value of a factor is assumed to be equal to a + bx, where a and b are constants. The models predict a linear regression. Linear Regression,Log-Linear Models,Models, Linear,Linear Model,Linear Regressions,Log Linear Models,Log-Linear Model,Model, Linear,Model, Log-Linear,Models, Log-Linear,Regression, Linear,Regressions, Linear
D053719 Tandem Mass Spectrometry A mass spectrometry technique using two (MS/MS) or more mass analyzers. With two in tandem, the precursor ions are mass-selected by a first mass analyzer, and focused into a collision region where they are then fragmented into product ions which are then characterized by a second mass analyzer. A variety of techniques are used to separate the compounds, ionize them, and introduce them to the first mass analyzer. For example, for in GC-MS/MS, GAS CHROMATOGRAPHY-MASS SPECTROMETRY is involved in separating relatively small compounds by GAS CHROMATOGRAPHY prior to injecting them into an ionization chamber for the mass selection. Mass Spectrometry-Mass Spectrometry,Mass Spectrometry Mass Spectrometry,Mass Spectrometry, Tandem

Related Publications

Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
April 2016, Biomedical chromatography : BMC,
Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
August 2014, Journal of separation science,
Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
April 2011, Journal of pharmaceutical and biomedical analysis,
Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
August 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
April 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
August 2003, Journal of mass spectrometry : JMS,
Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
August 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
January 2006, Journal of pharmaceutical and biomedical analysis,
Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
June 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Chengtao Lu, and Yanyan Jia, and Ying Song, and Xueqing Li, and Yuan Sun, and Jinyi Zhao, and Shan Wang, and Lei Shi, and Aidong Wen, and Li Ding
August 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
Copied contents to your clipboard!